Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	IMP dehydrogenase activity	IMPDH1 IMPDH2	3.17e-05	2	113	2	GO:0003938
GeneOntologyMolecularFunction	dioxygenase activity	KDM5D JMJD1C JMJD7 TET1 FTO	2.37e-04	98	113	5	GO:0051213
GeneOntologyMolecularFunction	transaminase activity	PHYKPL OAT KYAT1	4.17e-04	26	113	3	GO:0008483
GeneOntologyMolecularFunction	ATP-activated inward rectifier potassium channel activity	KCNJ1 KCNJ10	4.69e-04	6	113	2	GO:0015272
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM5D JMJD7 TET1 FTO	5.05e-04	65	113	4	GO:0016706
GeneOntologyMolecularFunction	transferase activity, transferring nitrogenous groups	PHYKPL OAT KYAT1	5.21e-04	28	113	3	GO:0016769
GeneOntologyMolecularFunction	extracellular matrix binding	ZAN TGFBI NTN4 NID1	7.84e-04	73	113	4	GO:0050840
GeneOntologyMolecularFunction	laminin-1 binding	NTN4 NID1	8.69e-04	8	113	2	GO:0043237
GeneOntologyBiologicalProcess	in utero embryonic development	HIF1A RPGRIP1L NCKAP1 SPEG CUBN CR1 BIRC6 GLI3 TTLL4 SUV39H1 TET1 MFN2 C6	1.93e-05	596	111	13	GO:0001701
GeneOntologyBiologicalProcess	embryo development	HIF1A RPGRIP1L DEAF1 NCKAP1 SPEG LAMA2 TDG CUBN CR1 BIRC6 HOXA2 BRCA1 NFE2L2 GLI3 TTLL4 SUV39H1 TET1 MFN2 C6 CPLANE1 NDRG4	2.37e-05	1437	111	21	GO:0009790
GeneOntologyBiologicalProcess	chordate embryonic development	HIF1A RPGRIP1L DEAF1 NCKAP1 SPEG CUBN CR1 BIRC6 HOXA2 BRCA1 GLI3 TTLL4 SUV39H1 TET1 MFN2 C6	2.74e-05	906	111	16	GO:0043009
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	HIF1A RPGRIP1L DEAF1 NCKAP1 SPEG CUBN CR1 BIRC6 HOXA2 BRCA1 GLI3 TTLL4 SUV39H1 TET1 MFN2 C6	3.71e-05	929	111	16	GO:0009792
GeneOntologyBiologicalProcess	positive regulation of activation of membrane attack complex	CR1 C6	8.58e-05	3	111	2	GO:0001970
Domain	EGF_1	ZAN LAMA2 CUBN ADGRE2 SSPOP CRB1 NTN4 EYS FAT2 NID1 C6	4.22e-07	255	113	11	PS00022
Domain	EGF-like_CS	ZAN LAMA2 CUBN ADGRE2 CRB1 NTN4 EYS FAT2 NID1 C6	4.20e-06	261	113	10	IPR013032
Domain	EGF_2	ZAN LAMA2 CUBN ADGRE2 SSPOP CRB1 EYS FAT2 NID1 C6	4.80e-06	265	113	10	PS01186
Domain	EGF_3	ZAN CUBN ADGRE2 SSPOP CRB1 EYS FAT2 NID1 C6	1.30e-05	235	113	9	PS50026
Domain	EGF-like_dom	ZAN LAMA2 CUBN ADGRE2 CRB1 EYS FAT2 NID1 C6	2.06e-05	249	113	9	IPR000742
Domain	IMP_DH	IMPDH1 IMPDH2	3.63e-05	2	113	2	IPR005990
Domain	LAM_G_DOMAIN	LAMA2 CRB1 EYS FAT2	8.00e-05	38	113	4	PS50025
Domain	EGF	ZAN LAMA2 CUBN ADGRE2 CRB1 EYS FAT2 NID1	9.17e-05	235	113	8	SM00181
Domain	EGF_CA	CUBN ADGRE2 CRB1 EYS FAT2 NID1	9.81e-05	122	113	6	SM00179
Domain	Laminin_G_2	LAMA2 CRB1 EYS FAT2	9.81e-05	40	113	4	PF02210
Domain	EGF-like_Ca-bd_dom	CUBN ADGRE2 CRB1 EYS FAT2 NID1	1.07e-04	124	113	6	IPR001881
Domain	EGF	ZAN CUBN CRB1 EYS FAT2 NID1	1.17e-04	126	113	6	PF00008
Domain	LamG	LAMA2 CRB1 EYS FAT2	1.43e-04	44	113	4	SM00282
Domain	Ndr	NDRG1 NDRG4	2.16e-04	4	113	2	PF03096
Domain	IMPDH	IMPDH1 IMPDH2	2.16e-04	4	113	2	PF00478
Domain	NDRG	NDRG1 NDRG4	2.16e-04	4	113	2	IPR004142
Domain	IMP_DH_GMPRt	IMPDH1 IMPDH2	2.16e-04	4	113	2	IPR001093
Domain	IMP_DH_GMP_RED	IMPDH1 IMPDH2	2.16e-04	4	113	2	PS00487
Domain	IMP_DH/GMP_Rdtase_CS	IMPDH1 IMPDH2	2.16e-04	4	113	2	IPR015875
Domain	FA58C	SSPOP F8 CPXM1	2.65e-04	21	113	3	SM00231
Domain	FA58C_3	SSPOP F8 CPXM1	2.65e-04	21	113	3	PS50022
Domain	FA58C_1	SSPOP F8 CPXM1	2.65e-04	21	113	3	PS01285
Domain	FA58C_2	SSPOP F8 CPXM1	2.65e-04	21	113	3	PS01286
Domain	Galactose-bd-like	LAMA2 SSPOP F8 NTN4 CPXM1	2.65e-04	94	113	5	IPR008979
Domain	EGF_Ca-bd_CS	CUBN ADGRE2 CRB1 EYS NID1	3.07e-04	97	113	5	IPR018097
Domain	EGF_CA	CUBN ADGRE2 CRB1 EYS NID1	3.37e-04	99	113	5	PS01187
Domain	ASX_HYDROXYL	CUBN ADGRE2 CRB1 EYS NID1	3.54e-04	100	113	5	PS00010
Domain	Aminotrans_3	PHYKPL OAT	3.59e-04	5	113	2	IPR005814
Domain	Aminotran_3	PHYKPL OAT	3.59e-04	5	113	2	PF00202
Domain	AA_TRANSFER_CLASS_3	PHYKPL OAT	3.59e-04	5	113	2	PS00600
Domain	Growth_fac_rcpt_	CUBN ADGRE2 CRB1 NTN4 EYS NID1	3.73e-04	156	113	6	IPR009030
Domain	F5_F8_type_C	SSPOP F8 CPXM1	3.98e-04	24	113	3	PF00754
Domain	FA58C	SSPOP F8 CPXM1	3.98e-04	24	113	3	IPR000421
Domain	Laminin_G	LAMA2 CRB1 EYS FAT2	4.19e-04	58	113	4	IPR001791
Domain	EGF-type_Asp/Asn_hydroxyl_site	CUBN ADGRE2 CRB1 EYS NID1	4.62e-04	106	113	5	IPR000152
Domain	JMJC	KDM5D JMJD1C JMJD7	9.41e-04	32	113	3	PS51184
Domain	JmjC_dom	KDM5D JMJD1C JMJD7	9.41e-04	32	113	3	IPR003347
Domain	-	DCAF8L2 GNB1L COPB2 NUP43 SEMA5A BIRC6 MET TLE2	9.49e-04	333	113	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF8L2 GNB1L COPB2 NUP43 SEMA5A BIRC6 MET TLE2	9.86e-04	335	113	8	IPR015943
Domain	-	LAMA2 SSPOP F8 CPXM1	1.00e-03	73	113	4	2.60.120.260
Domain	JmjC	KDM5D JMJD1C JMJD7	1.03e-03	33	113	3	SM00558
Domain	-	PHYKPL OAT KYAT1	1.23e-03	35	113	3	3.90.1150.10
Domain	PyrdxlP-dep_Trfase_major_sub2	PHYKPL OAT KYAT1	1.33e-03	36	113	3	IPR015422
Domain	-	PHYKPL OAT KYAT1	1.68e-03	39	113	3	3.40.640.10
Domain	LDLR_class-A_CS	LDLRAD3 SSPOP C6	1.81e-03	40	113	3	IPR023415
Domain	Laminin_G_1	LAMA2 EYS	1.93e-03	11	113	2	PF00054
Domain	PyrdxlP-dep_Trfase	PHYKPL OAT KYAT1	1.94e-03	41	113	3	IPR015424
Domain	PyrdxlP-dep_Trfase_major_sub1	PHYKPL OAT KYAT1	1.94e-03	41	113	3	IPR015421
Domain	EGF_dom	CUBN NID1	2.30e-03	12	113	2	IPR024731
Domain	C8	ZAN SSPOP	2.30e-03	12	113	2	PF08742
Domain	EGF_3	CUBN NID1	2.30e-03	12	113	2	PF12947
Domain	TIL	ZAN SSPOP	2.30e-03	12	113	2	PF01826
Domain	Ldl_recept_a	LDLRAD3 SSPOP C6	2.54e-03	45	113	3	PF00057
Domain	-	LAMA2 CRB1 EYS FAT2	2.65e-03	95	113	4	2.60.120.200
Domain	Unchr_dom_Cys-rich	ZAN SSPOP	2.71e-03	13	113	2	IPR014853
Domain	C8	ZAN SSPOP	2.71e-03	13	113	2	SM00832
Domain	LDLRA_1	LDLRAD3 SSPOP C6	3.06e-03	48	113	3	PS01209
Domain	TIL_dom	ZAN SSPOP	3.15e-03	14	113	2	IPR002919
Domain	LDrepeatLR_classA_rpt	LDLRAD3 SSPOP C6	3.24e-03	49	113	3	IPR002172
Domain	LDLa	LDLRAD3 SSPOP C6	3.24e-03	49	113	3	SM00192
Domain	LDLRA_2	LDLRAD3 SSPOP C6	3.24e-03	49	113	3	PS50068
Domain	Sushi	CSMD2 CR1 C6	3.84e-03	52	113	3	PF00084
Domain	CBS	IMPDH1 IMPDH2	4.12e-03	16	113	2	SM00116
Domain	VWF_type-D	ZAN SSPOP	4.12e-03	16	113	2	IPR001846
Domain	Laminin_N	LAMA2 NTN4	4.12e-03	16	113	2	IPR008211
Domain	VWFD	ZAN SSPOP	4.12e-03	16	113	2	PS51233
Domain	IRK	KCNJ1 KCNJ10	4.12e-03	16	113	2	PF01007
Domain	LamNT	LAMA2 NTN4	4.12e-03	16	113	2	SM00136
Domain	VWD	ZAN SSPOP	4.12e-03	16	113	2	SM00216
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ1 KCNJ10	4.12e-03	16	113	2	IPR013518
Domain	LAMININ_NTER	LAMA2 NTN4	4.12e-03	16	113	2	PS51117
Domain	Laminin_N	LAMA2 NTN4	4.12e-03	16	113	2	PF00055
Domain	-	KCNJ1 KCNJ10	4.12e-03	16	113	2	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ1 KCNJ10	4.12e-03	16	113	2	IPR016449
Domain	VWD	ZAN SSPOP	4.12e-03	16	113	2	PF00094
Domain	CCP	CSMD2 CR1 C6	4.27e-03	54	113	3	SM00032
Domain	EMI	SSPOP TGFBI	4.65e-03	17	113	2	PS51041
Domain	SUSHI	CSMD2 CR1 C6	4.74e-03	56	113	3	PS50923
Domain	Sushi_SCR_CCP_dom	CSMD2 CR1 C6	4.98e-03	57	113	3	IPR000436
Domain	VWC_out	ZAN SSPOP	5.80e-03	19	113	2	SM00215
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	HIF1A TES DEAF1 FOXJ3 BIRC6 MET NDRG1 BRCA1 GLI3 MKI67 NDRG4 NR1D2	3.90e-06	709	114	12	22988430
Pubmed	Expression of IMPDH mRNA after mycophenolate administration in male volunteers.	IMPDH1 IMPDH2	1.07e-05	2	114	2	25105143
Pubmed	Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.	HIF1A NFE2L2	1.07e-05	2	114	2	23930677
Pubmed	FANCJ helicase controls the balance between short- and long-tract gene conversions between sister chromatids.	BRIP1 BRCA1	1.07e-05	2	114	2	28911102
Pubmed	Hydrogen sulphide induces HIF-1α and Nrf2 in THP-1 macrophages.	HIF1A NFE2L2	1.07e-05	2	114	2	25795259
Pubmed	Association of fat mass and obesity-associated and retinitis pigmentosa guanosine triphosphatase (GTPase) regulator-interacting protein-1 like polymorphisms with body mass index in Chinese women.	RPGRIP1L FTO	1.07e-05	2	114	2	29657248
Pubmed	Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.	HIF1A NDRG1	1.07e-05	2	114	2	28498432
Pubmed	CRB1rd8 mutation influences the age-related macular degeneration phenotype of NRF2 knockout mice and favors choroidal neovascularization.	CRB1 NFE2L2	1.07e-05	2	114	2	31918066
Pubmed	Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.	IMPDH1 IMPDH2	1.07e-05	2	114	2	12944494
Pubmed	Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1.	BRIP1 BRCA1	1.07e-05	2	114	2	33619228
Pubmed	HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer.	HIF1A NFE2L2	1.07e-05	2	114	2	35644470
Pubmed	Breast cancer susceptibility gene 1 regulates oxidative damage via nuclear factor erythroid 2-related factor 2 in oral cancer cells.	BRCA1 NFE2L2	1.07e-05	2	114	2	35512617
Pubmed	Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.	HIF1A MKI67	1.07e-05	2	114	2	24577133
Pubmed	Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs.	IMPDH1 IMPDH2	1.07e-05	2	114	2	2902093
Pubmed	HIF1α/TET1 Pathway Mediates Hypoxia-Induced Adipocytokine Promoter Hypomethylation in Human Adipocytes.	HIF1A TET1	1.07e-05	2	114	2	31935962
Pubmed	NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.	HIF1A NFE2L2	1.07e-05	2	114	2	21278237
Pubmed	Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.	IMPDH1 IMPDH2	1.07e-05	2	114	2	14766016
Pubmed	HIF-1α up-regulates NDRG1 expression through binding to NDRG1 promoter, leading to proliferation of lung cancer A549 cells.	HIF1A NDRG1	1.07e-05	2	114	2	23526365
Pubmed	Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene.	IMPDH1 IMPDH2	1.07e-05	2	114	2	7896827
Pubmed	m6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation.	HIF1A FTO	1.07e-05	2	114	2	34569703
Pubmed	Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.	NFE2L2 TET1	1.07e-05	2	114	2	24743738
Pubmed	NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.	HIF1A NFE2L2	1.07e-05	2	114	2	29275212
Pubmed	Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.	BRIP1 BRCA1	1.07e-05	2	114	2	15242590
Pubmed	Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients.	HIF1A MKI67	1.07e-05	2	114	2	25967708
Pubmed	Correlations between the iodine concentrations from dual energy computed tomography and molecular markers Ki-67 and HIF-1α in rectal cancer: A preliminary study.	HIF1A MKI67	1.07e-05	2	114	2	29103468
Pubmed	Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle.	HIF1A NFE2L2	1.07e-05	2	114	2	30513114
Pubmed	Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.	IMPDH1 IMPDH2	1.07e-05	2	114	2	20718729
Pubmed	Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence.	BRIP1 BRCA1	1.07e-05	2	114	2	22137763
Pubmed	Two distinct cDNAs for human IMP dehydrogenase.	IMPDH1 IMPDH2	1.07e-05	2	114	2	1969416
Pubmed	Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.	HIF1A MKI67	1.07e-05	2	114	2	26456310
Pubmed	Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene.	BRCA1 NFE2L2	1.07e-05	2	114	2	23353771
Pubmed	Regulation of FTO and FTM expression during human preadipocyte differentiation.	RPGRIP1L FTO	1.07e-05	2	114	2	20865646
Pubmed	High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.	HIF1A BRCA1	1.07e-05	2	114	2	18030615
Pubmed	Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.	BRIP1 BRCA1	1.07e-05	2	114	2	18717574
Pubmed	Hypoxia-induced TET1 facilitates trophoblast cell migration and invasion through HIF1α signaling pathway.	HIF1A TET1	1.07e-05	2	114	2	28808304
Pubmed	Characterization of human type I and type II IMP dehydrogenases.	IMPDH1 IMPDH2	1.07e-05	2	114	2	7903306
Pubmed	Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.	IMPDH1 IMPDH2	1.07e-05	2	114	2	7763314
Pubmed	Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.	MET NFE2L2	1.07e-05	2	114	2	28676836
Pubmed	Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.	HIF1A NFE2L2	1.07e-05	2	114	2	32556090
Pubmed	Biochemical and immunomorphological evaluation of hepatocyte growth factor and c-Met pathway in patients with critical limb ischemia.	HIF1A MET	1.07e-05	2	114	2	24947080
Pubmed	Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis.	HIF1A NFE2L2	1.07e-05	2	114	2	32566088
Pubmed	Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.	IMPDH1 IMPDH2	1.07e-05	2	114	2	20679962
Pubmed	Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.	IMPDH1 IMPDH2	1.07e-05	2	114	2	17713475
Pubmed	Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.	BRIP1 BRCA1	1.07e-05	2	114	2	15125843
Pubmed	Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α.	HIF1A NFE2L2	1.07e-05	2	114	2	36460215
Pubmed	Mutants of purine metabolism in cultured mouse and hamster cells.	IMPDH1 IMPDH2	1.07e-05	2	114	2	988789
Pubmed	Identification of a functional antioxidant response element at the HIF1A locus.	HIF1A NFE2L2	1.07e-05	2	114	2	30241031
Pubmed	Crystal Structure of Human Leukocyte Cell-derived Chemotaxin 2 (LECT2) Reveals a Mechanistic Basis of Functional Evolution in a Mammalian Protein with an M23 Metalloendopeptidase Fold.	LECT2 MET	1.07e-05	2	114	2	27334921
Pubmed	BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.	BRIP1 BRCA1	1.07e-05	2	114	2	22032289
Pubmed	Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.	BRIP1 BRCA1	1.07e-05	2	114	2	15133502
Pubmed	Induction of apoptosis and cellular senescence in mice lacking transcription elongation factor, Elongin A.	HIF1A NDRG1 MKI67	2.26e-05	17	114	3	17170753
Pubmed	FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.	NFE2L2 FTO	3.19e-05	3	114	2	36878272
Pubmed	Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.	BRIP1 BRCA1	3.19e-05	3	114	2	19452558
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 MKI67	3.19e-05	3	114	2	27163153
Pubmed	BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.	BRIP1 BRCA1	3.19e-05	3	114	2	11301010
Pubmed	FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein.	BRIP1 BRCA1	3.19e-05	3	114	2	17596542
Pubmed	Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.	HIF1A MET	3.19e-05	3	114	2	20154724
Pubmed	Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1.	NEIL2 NFE2L2	3.19e-05	3	114	2	24366543
Pubmed	Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.	TGFBI NFE2L2	3.19e-05	3	114	2	28261610
Pubmed	Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.	BRIP1 BRCA1	3.19e-05	3	114	2	18285836
Pubmed	T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly.	IMPDH1 IMPDH2	3.19e-05	3	114	2	30154209
Pubmed	Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism.	HIF1A NFE2L2	3.19e-05	3	114	2	29153923
Pubmed	NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis.	HIF1A NFE2L2	3.19e-05	3	114	2	32791852
Pubmed	Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.	TDG TET1	3.19e-05	3	114	2	26207381
Pubmed	CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.	BRCA1 NFE2L2	3.19e-05	3	114	2	34103686
Pubmed	Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment.	LECT2 MET	3.19e-05	3	114	2	24114941
Pubmed	Genetic markers and continuity of healthy metabolic status: Tehran cardio-metabolic genetic study (TCGS).	SLC39A8 FTO	3.19e-05	3	114	2	32788640
Pubmed	Neil DNA glycosylases promote substrate turnover by Tdg during DNA demethylation.	NEIL2 TDG	3.19e-05	3	114	2	26751644
Pubmed	UBXN7 cofactor of CRL3KEAP1 and CRL2VHL ubiquitin ligase complexes mediates reciprocal regulation of NRF2 and HIF-1α proteins.	HIF1A NFE2L2	3.19e-05	3	114	2	33444648
Pubmed	BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation.	HIF1A BRCA1	3.19e-05	3	114	2	30254159
Pubmed	FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.	BRIP1 BRCA1	3.19e-05	3	114	2	32797166
Pubmed	Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA.	TDG TET1	3.19e-05	3	114	2	24838012
Pubmed	TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.	TDG TET1	3.19e-05	3	114	2	36764492
Pubmed	MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.	HIF1A MKI67	3.19e-05	3	114	2	26919464
Pubmed	c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming.	IMPDH1 IMPDH2	3.19e-05	3	114	2	36629054
Pubmed	DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.	NEIL2 BRCA1	3.19e-05	3	114	2	24698998
Pubmed	Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.	BRCA1 MKI67	3.19e-05	3	114	2	23614934
Pubmed	Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.	HIF1A NFE2L2	3.19e-05	3	114	2	23404377
Pubmed	Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.	BRIP1 BRCA1	3.19e-05	3	114	2	19484476
Pubmed	HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.	HIF1A NFE2L2	3.19e-05	3	114	2	19254160
Pubmed	Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel.	HIF1A NDRG1	3.19e-05	3	114	2	16288478
Pubmed	BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.	BRCA1 MKI67	3.19e-05	3	114	2	29465506
Pubmed	The LIM domain protein Lmo4 is highly expressed in proliferating mouse epithelial tissues.	DEAF1 MKI67	3.19e-05	3	114	2	15805422
Pubmed	MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.	HIF1A TET1	3.19e-05	3	114	2	35942521
Pubmed	Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.	HIF1A MET	3.19e-05	3	114	2	29717265
Pubmed	HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.	HIF1A BRCA1	3.19e-05	3	114	2	23409121
Pubmed	Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk.	BRCA1 MKI67	3.19e-05	3	114	2	24196303
Pubmed	BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.	BRIP1 BRCA1	3.19e-05	3	114	2	25483079
Pubmed	miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission.	HIF1A MFN2	3.19e-05	3	114	2	29749475
Pubmed	Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease.	HIF1A CD79A	3.19e-05	3	114	2	29343683
Pubmed	CtIP- and ATR-dependent FANCJ phosphorylation in response to DNA strand breaks mediated by DNA replication.	BRIP1 BRCA1	3.19e-05	3	114	2	23157317
Pubmed	Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.	MET BRCA1	3.19e-05	3	114	2	16585167
Pubmed	Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.	NID1 NDRG4	3.19e-05	3	114	2	33890711
Pubmed	Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability.	HIF1A NFE2L2	3.19e-05	3	114	2	29485192
Pubmed	Tnpo3 enables EBF1 function in conditions of antagonistic Notch signaling.	CD79A TNPO3	3.19e-05	3	114	2	36167471
Pubmed	Ciliary gene RPGRIP1L is required for hypothalamic arcuate neuron development.	RPGRIP1L FTO	3.19e-05	3	114	2	30728336
Pubmed	MiR-125b attenuates retinal pigment epithelium oxidative damage via targeting Nrf2/HIF-1α signal pathway.	HIF1A NFE2L2	3.19e-05	3	114	2	34875217
Pubmed	ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1/EXO1.	ZGRF1 BRCA1	3.19e-05	3	114	2	34552057
Pubmed	Expressions of NDRG1, VEGF and Ki-67 in Condyloma Acuminatum.	NDRG1 MKI67	3.19e-05	3	114	2	27655496
Pubmed	CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1α under hypoxic conditions.	HIF1A NFE2L2	3.19e-05	3	114	2	33771976
GeneFamily	Ankyrin repeat domain containing\|BRCA1 B complex	BRIP1 BRCA1	1.04e-04	4	76	2	1335
GeneFamily	DNA glycosylases	NEIL2 TDG	9.36e-04	11	76	2	1024
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CR1 C6	1.77e-03	57	76	3	1179
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ1 KCNJ10	2.01e-03	16	76	2	276
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRIP1 BRCA1	3.15e-03	20	76	2	548
Coexpression	GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	LDLRAD3 FOXJ3 POLR3F MED15 TNFAIP2 MED7 GNS NR1D2	2.58e-06	200	113	8	M7859
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	REC114 LAMA2 SEMA5A OAT KDM5D ADGRA2 PCDH17 RNF170 TGFBI MET PHC3 TLE2 TET1 GKAP1 CPXM1 METTL25 MBD5 CPLANE1	2.95e-05	1166	110	18	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000	BRIP1 ZGRF1 GLI3 TET1 MKI67	3.38e-05	71	110	5	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	BRIP1 IMPDH2 SCRG1 SH2D5 TGFBI BRCA1 TET1 MKI67 CD79A TNFAIP2	4.91e-05	405	110	10	GSM538343_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1	C15orf62 ZNF157 LAMA2 SEMA5A OAT ADGRA2 HOXA2 TGFBI PHC3 CPXM1 NID1 FTO	5.50e-05	589	110	12	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	BRIP1 REC114 ZGRF1 BRCA1 SUV39H1 GKAP1 METTL25 CPLANE1 NR1D2	1.10e-04	361	110	9	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2	C15orf62 ZNF157 LAMA2 SEMA5A OAT ADGRA2 SLC39A8 TGFBI PHC3 CPXM1 NID1 FTO	1.24e-04	642	110	12	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	C15orf62 TES LAMA2 SEMA5A OAT ADGRA2 SLC39A8 PHC3 GLI3 MKI67 CPXM1 NID1 FTO	1.26e-04	744	110	13	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HIF1A SRGAP2 CR1 JMJD1C MET TNFAIP2 GNS	7.95e-07	198	114	7	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OSTM1 LDLRAD3 SUV39H1 TNFAIP2 MBD5 CPLANE1	4.74e-06	168	114	6	27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAG1 F8 LAX1 LRIG2 NDRG1 KCNJ1	5.42e-06	172	114	6	b3c4adccc34bb9e4e78e40f4e2e23736c347cc75
ToppCell	facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAG1 F8 LAX1 LRIG2 NDRG1 KCNJ1	5.42e-06	172	114	6	2f1673fcb2356684d60871debb0f159aec553a1c
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD3 TGFBI MET NDRG1 MKI67 TNFAIP2	6.60e-06	178	114	6	be8af4d85b8835a85a168639c37857dcaa6b00bf
ToppCell	PBMC-Control-cDC_12\|Control / Compartment, Disease Groups and Clusters	BRIP1 SLC39A8 BRCA1 KCNJ10 SUV39H1 MKI67	7.49e-06	182	114	6	4774066d0f9986abc3d13a2a3bc99ce4f1327ae0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 ADGRA2 BRCA1 GLI3 MKI67	8.74e-06	187	114	6	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 ADGRA2 BRCA1 GLI3 MKI67	8.74e-06	187	114	6	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 JMJD1C TGFBI PRRC2C CPXM1 NID1	1.02e-05	192	114	6	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 SEMA5A TGFBI CPXM1 NID1 NDRG4	1.02e-05	192	114	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	HIF1A LDLRAD3 ADGRE2 PRAG1 TGFBI MET	1.02e-05	192	114	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	368C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 ZGRF1 SUV39H1 MKI67 CPXM1 CPLANE1	1.05e-05	193	114	6	5f5904cec8b2967154ef2eab3c48f51df53aca4a
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIF1A ADGRE2 CR1 MCOLN1 JMJD1C TNFAIP2	1.08e-05	194	114	6	dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 SEMA5A LDLRAD3 ADGRA2 TGFBI NID1	1.11e-05	195	114	6	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	5'-Adult-Appendix\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HIF1A LAMA2 F8 CPXM1 NID1 TNFAIP2	1.14e-05	196	114	6	a579211ef14f348d0c5a290553150222dfbf1515
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IMPDH2 CAMK2B SEMA5A OAT FAT2 NFE2L2	1.21e-05	198	114	6	b411fb9f16eb641593f546c5f3a0db37b05c1f4f
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LAMA2 SCRG1 PRAG1 SLC39A8 TGFBI MET	1.28e-05	200	114	6	47791c93d03ee17c1ce17e27f075be4fc6f2590e
ToppCell	Transverse-(2)_B_cell-(24)_B_cell_cycling\|Transverse / shred on region, Cell_type, and subtype	BRIP1 CR1 FOXJ3 BRCA1 SUV39H1 MKI67	1.28e-05	200	114	6	e3f9736227151f23f0e331eec0a7a15ce464b517
ToppCell	Transverse-B_cell-B_cell_cycling\|Transverse / Region, Cell class and subclass	BRIP1 CR1 FOXJ3 BRCA1 SUV39H1 MKI67	1.28e-05	200	114	6	0e270f8019d9f22068ca426d661937262a5cd331
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LAMA2 SCRG1 PRAG1 SLC39A8 TGFBI MET	1.28e-05	200	114	6	f75d95376a340d467c4392b872b2a2dbdd184556
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LAMA2 SCRG1 PRAG1 SLC39A8 TGFBI MET	1.28e-05	200	114	6	fae26560ba3b0b638b6bcf92f05330824b31d21b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	CSMD2 JMJD1C LRIG2 NTN4 EYS	2.55e-05	135	114	5	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA2 SCRG1 NFE2L2 GLI3 KCNJ10	4.64e-05	153	114	5	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA2 SCRG1 NFE2L2 GLI3 KCNJ10	4.64e-05	153	114	5	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA2 SCRG1 NFE2L2 GLI3 KCNJ10	4.64e-05	153	114	5	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CUBN PRAG1 TGFBI TNFAIP2 GNS	5.41e-05	158	114	5	6811dc4f101dfa9a9cc13d949760d43aa522bf3b
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	LAMA2 TGFBI CPXM1 NID1 TNFAIP2	5.57e-05	159	114	5	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZGRF1 F8 PCDH17 BRCA1 MKI67	6.27e-05	163	114	5	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TES NEIL2 ZNF280B ZNF850 ZNF782	6.45e-05	164	114	5	4ade97931ae1780af7836d988fe117a10b3e88a1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 HOXA2 BRCA1 MKI67	6.64e-05	165	114	5	88681101d7cf60b99b8ace5d8c0944323b937306
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	C15orf62 MUC16 NTN4 NDRG1 KLHL14	7.03e-05	167	114	5	720dc5855c856b478b5ca90156b30bfcc5518d60
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LDLRAD3 TGFBI NTN4 GLI3 CPXM1	7.43e-05	169	114	5	7cb1b87be66a22fe5731bb1b55bc515920fe3e8b
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD3 TGFBI KCNJ10 TNFAIP2 C6	7.64e-05	170	114	5	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	C15orf62 BRIP1 SUV39H1 MKI67 MED7	7.64e-05	170	114	5	21bfe070e63722672176052b386167ea4c3dc4e5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRGAP2 LDLRAD3 LECT2 TGFBI MET	7.64e-05	170	114	5	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRGAP2 LDLRAD3 LECT2 TGFBI MET	7.64e-05	170	114	5	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZAN KCNJ10 MKI67 TNFAIP2 GNS	7.86e-05	171	114	5	845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 LAMA2 SCRG1 MKI67	7.86e-05	171	114	5	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 LAMA2 SCRG1 MKI67	7.86e-05	171	114	5	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF280B SPACA9 PCDH17 ZNF782 GNS	8.08e-05	172	114	5	d65ffff3e341af34a043a0d802d7ba4b69de36e9
ToppCell	droplet-Liver-nan-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA5A PLPPR1 KCNJ10 TNFAIP2 C6	8.08e-05	172	114	5	1f335ccb92b22d0412954e8fc3af212f96410b67
ToppCell	droplet-Liver-nan-3m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA5A PLPPR1 KCNJ10 TNFAIP2 C6	8.08e-05	172	114	5	bb96c896d125e10b71e94e2bdad243899045af5c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA2 SCRG1 SLC39A8 TGFBI MET	8.30e-05	173	114	5	8ac2e9d39c0f76e674f8bd59d1da246bab4867c8
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BRIP1 ZGRF1 PCDH17 BRCA1 MKI67	8.53e-05	174	114	5	66555c610251ea04f968c258e312d720c18e7cde
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA2 SEMA5A LDLRAD3 PRAG1 TGFBI	8.76e-05	175	114	5	3f233a7e19f594e0343f02286299cc42c711994c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA2 SEMA5A LDLRAD3 PRAG1 TGFBI	8.76e-05	175	114	5	23acfbcc1eb5a066195a9fde20aa51b7303a81af
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	METAP1D KDM5D CD79A ZNF606 METTL25	8.76e-05	175	114	5	87e557f7508c88b2087db5d57e77d5e2c92ca083
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD3 TGFBI KCNJ10 TNFAIP2 C6	8.76e-05	175	114	5	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	primary_visual_cortex-Non-neuronal\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA2 SCRG1 NFE2L2 GLI3 KCNJ10	9.00e-05	176	114	5	2c92f3f55d668cfe80051b5128160a6dc3aec4e8
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C15orf62 ADGRE2 CR1 TGFBI GNS	9.24e-05	177	114	5	382f0d6bbff01e84b0c7840e74ac865864e6da89
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCRG1 ADGRA2 PCDH17 HOXA2 NTN4	9.24e-05	177	114	5	1921226196b2ab7919d9f843e60d9f4bd9ec9c57
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRIP1 ZGRF1 SPEG PRAG1 MCOLN1	9.49e-05	178	114	5	de6cd81e6d58e7687386df163471bf1901b9c0aa
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHYKPL KCNJ1 CD79A KLHL14	9.59e-05	93	114	4	096a207dfd280b23480bc068a15e6947423620c5
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHYKPL KCNJ1 CD79A KLHL14	9.59e-05	93	114	4	6977ae7eccb45fbc48960a0945be9ccc7566ca8b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA5A CUBN SLC39A8 MET TNFAIP2	9.75e-05	179	114	5	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SRGAP2 ADGRE2 SSPOP TGFBI TNFAIP2	1.00e-04	180	114	5	66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 ZGRF1 CSMD2 BRCA1 MKI67	1.00e-04	180	114	5	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 ADGRA2 F8 PCDH17 NID1	1.08e-04	183	114	5	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 ADGRA2 F8 PCDH17 NID1	1.08e-04	183	114	5	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIF1A LDLRAD3 ADGRE2 CR1 TGFBI	1.11e-04	184	114	5	d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCell	NS-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP1 OAT PCDH17 FAT2 TLE2	1.17e-04	186	114	5	c28f62524637c7eb9c43c9ec38fb12dfec6f5566
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BRIP1 PCDH17 CRB1 BRCA1 MKI67	1.17e-04	186	114	5	4fe8e0bf74c7dbf73634cafdacad89020d2634d0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPEG SEMA5A PRAG1 TGFBI TLE2	1.20e-04	187	114	5	387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	F8 PCDH17 MET NDRG1 NDRG4	1.20e-04	187	114	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CR1 SLC39A8 TGFBI TNFAIP2 GNS	1.23e-04	188	114	5	5f6ad5d693145d846ca561c2fa55465a88e40b90
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 SH2D5 HOXA2 CPXM1 NID1	1.26e-04	189	114	5	544d95df910f1b276995624509a7e41b219baca0
ToppCell	Control-Myeloid-MoAM1\|Control / Disease group,lineage and cell class （2021.01.30）	HIF1A ADGRE2 SSPOP SLC39A8 TGFBI	1.26e-04	189	114	5	55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HIF1A ADGRE2 MCOLN1 TGFBI TNFAIP2	1.29e-04	190	114	5	00ef6ec71353e42260c0d807d7da65b63154c288
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HIF1A ADGRE2 MCOLN1 TGFBI TNFAIP2	1.29e-04	190	114	5	18c020ca9a23399214133ec255ab870e0060f2e1
ToppCell	wk_08-11-Epithelial-PNS-Early_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SCRG1 LENG9 KYAT1 PCDH17 KCNJ10	1.29e-04	190	114	5	8190674a48607984726974765aafbca116f437e0
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB38 IMPDH2 SEMA5A PRRC2C MKI67	1.29e-04	190	114	5	52c59001a079c76249abbaa3141e9e661b83d9a0
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TGFBI CPXM1 NID1 TNFAIP2	1.29e-04	190	114	5	ad0f5605db6b694445ec9bd5dc8d2d834358c0f9
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 NTN4 PRRC2C NID1 TNFAIP2	1.32e-04	191	114	5	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRE2 CR1 TGFBI TNFAIP2 GNS	1.32e-04	191	114	5	c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 LDLRAD3 ADGRA2 GLI3 NID1	1.32e-04	191	114	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 LDLRAD3 ADGRA2 GLI3 NID1	1.32e-04	191	114	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRE2 CR1 TGFBI TNFAIP2 GNS	1.35e-04	192	114	5	b86476037ddf8904c1d8a6b3763af7242c031cf3
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRA2 F8 SLC39A8 PCDH17 NID1	1.35e-04	192	114	5	5890076929598e88fe9d59a4e4e858b446746ce9
ToppCell	Fibroblasts-CD55+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NCKAP1 SPEG SEMA5A MET NTN4	1.39e-04	193	114	5	8f4bf9a2fbedae35432dad96730b00c70185874c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 LDLRAD3 ADGRA2 GLI3 NID1	1.39e-04	193	114	5	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 ADGRA2 GLI3 CPXM1 NID1	1.39e-04	193	114	5	59b8186d0221fba06a16157e9d148399ed801f38
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRA2 F8 SLC39A8 PCDH17 NID1	1.39e-04	193	114	5	4a8c97ff2dffc5c06351d1cb107e21e58250aa55
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRA2 F8 SLC39A8 PCDH17 NID1	1.39e-04	193	114	5	d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 ADGRA2 GLI3 CPXM1 NID1	1.39e-04	193	114	5	dc92680b4bb9fc26430c92e03adb839c8c3b3b98
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 ADGRA2 GLI3 CPXM1 NID1	1.39e-04	193	114	5	03678162648bd5b1d65a5450b60c8863edbf95c7
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	PLPPR1 PRAG1 NDRG1 PRRC2C MBD5	1.39e-04	193	114	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	LAMA2 SEMA5A ADGRA2 CPXM1 NID1	1.42e-04	194	114	5	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	Non-neuronal-Non-dividing\|World / Primary Cells by Cluster	SCRG1 SEMA5A OAT NFE2L2 GLI3	1.42e-04	194	114	5	0add09d97192b34bd506209ab5f1a77182f498fc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 LDLRAD3 ADGRA2 GLI3 NID1	1.45e-04	195	114	5	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB38 LAMA2 JMJD1C PRRC2C CPXM1	1.45e-04	195	114	5	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG LAMA2 LDLRAD3 ADGRA2 NID1	1.49e-04	196	114	5	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	droplet-Heart-HEART-1m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LAMA2 SEMA5A NDRG4 NR1D2	1.49e-04	196	114	5	1eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TGFBI CPXM1 NID1 NR1D2	1.49e-04	196	114	5	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADGRE2 CR1 MCOLN1 TGFBI TNFAIP2	1.49e-04	196	114	5	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TGFBI CPXM1 NID1 NR1D2	1.49e-04	196	114	5	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HIF1A NCKAP1 COPB2 JMJD1C PTPRA	1.53e-04	197	114	5	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIF1A NCKAP1 COPB2 JMJD1C PTPRA	1.53e-04	197	114	5	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HIF1A ADGRE2 CR1 JMJD1C TNFAIP2	1.53e-04	197	114	5	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRIP1 ZAN PCDH17 MKI67 NID1	1.53e-04	197	114	5	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast\|ICU-NoSEP / Disease, condition lineage and cell class	BRIP1 LAX1 CPXM1 CD79A KLHL14	1.53e-04	197	114	5	8f35f9741086a38f0e594dce0547b575946f52bb
Drug	Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A	SPEG SEMA5A ZNF280B KYAT1 MET CD79A TNFAIP2 CPLANE1	6.85e-06	197	114	8	5054_UP
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A	FOXJ3 TGFBI MET PHC3 KCNJ1 CD79A ZNF606 NDRG4	7.38e-06	199	114	8	4615_DN
Drug	AC1L1BVU	F8 BRCA1 CD79A C6	1.11e-05	28	114	4	CID000001631
Drug	1 mN-9	IMPDH1 IMPDH2 NDRG1	1.43e-05	10	114	3	CID000122108
Drug	Vanadates	HIF1A TES CAMK2B ZNF280B KDM5D PRAG1 KYAT1 HOXA2 TGFBI MET NTN4 BRCA1 GLI3 GKAP1 NID1 CD79A TNFAIP2 FTO CPLANE1	2.41e-05	1302	114	19	ctd:D014638
Drug	hydroxymethylphosphonate	IMPDH1 IMPDH2	2.49e-05	2	114	2	CID000075795
Drug	6-Chloropurine Riboside, 5'-Monophosphate	IMPDH1 IMPDH2	2.49e-05	2	114	2	DB03948
Drug	Mycophenolate mofetil	IMPDH1 IMPDH2	2.49e-05	2	114	2	DB00688
Drug	purinogen	IMPDH1 IMPDH2	2.49e-05	2	114	2	CID003081226
Drug	AC1L9X6T	IMPDH1 IMPDH2	2.49e-05	2	114	2	CID000477594
Drug	Mycophenolic acid	IMPDH1 IMPDH2	2.49e-05	2	114	2	DB01024
Drug	6-thioxanthine	IMPDH1 IMPDH2 KYAT1	2.60e-05	12	114	3	CID001268107
Drug	gabaculine	PHYKPL OAT CPXM1 C6	2.77e-05	35	114	4	CID000003445
Drug	AC1L1IFV	HIF1A KDM5D PHC3 SUV39H1 CD79A	4.83e-05	79	114	5	CID000004561
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	BRIP1 SLC39A8 MET PHC3 RNFT1 MFN2 GNS	5.40e-05	193	114	7	6835_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	RPGRIP1L SPACA9 LAX1 MED15 PHC3 PTPRA TLE2	5.58e-05	194	114	7	4107_DN
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	NCKAP1 GNB1L RNF170 MET NID1 TNFAIP2 NDRG4	5.95e-05	196	114	7	6344_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SLC4A2 MED15 PHC3 NDRG1 GLI3 SUV39H1 NDRG4	5.95e-05	196	114	7	7183_DN
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A	BRIP1 GNB1L RXYLT1 MET TLE2 MFN2 NID1	6.15e-05	197	114	7	4613_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	BRIP1 GNB1L RNF170 MET RNFT1 MKI67 NID1	6.15e-05	197	114	7	2070_DN
Drug	Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; PC3; HT_HG-U133A	BRIP1 RPGRIP1L SEMA5A FOXJ3 MET TLE2 TNFAIP2	6.55e-05	199	114	7	6759_DN
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; PC3; HT_HG-U133A	LAMA2 PHF7 ZNF280B SPACA9 CR1 MET TNFAIP2	6.55e-05	199	114	7	4648_UP
Drug	clofibrate; Up 200; 100uM; MCF7; HG-U133A	SEMA5A MET PTPRA BRCA1 TTLL4 RNFT1 NDRG4	6.55e-05	199	114	7	444_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A	CAMK2B PHF7 SPACA9 LAX1 PCDH17 HOXA2 CPLANE1	6.76e-05	200	114	7	3682_DN
Drug	AC1L59F0	IMPDH1 IMPDH2	7.43e-05	3	114	2	CID000220847
Drug	toxin 6	CD79A GNS	7.43e-05	3	114	2	CID000126627
Drug	AC1L9X6Q	IMPDH1 IMPDH2	7.43e-05	3	114	2	CID000477593
Drug	oxanosine-5'-monophosphate	IMPDH1 IMPDH2	7.43e-05	3	114	2	CID000477551
Drug	glutamate	PHYKPL IMPDH1 CAMK2B OAT TDG MCOLN1 LECT2 NDUFV1 KYAT1 SLC4A2 NTN4 NFE2L2 KCNJ1 KCNJ10 TTLL4	9.16e-05	962	114	15	CID000000611
Disease	level of leukocyte cell-derived chemotaxin-2 in blood serum	LECT2 TGFBI	1.43e-05	2	112	2	OBA_2042187
Disease	Multiple Hemangioblastomas	HIF1A NDRG1	1.43e-05	2	112	2	C0751692
Disease	Hemangioblastoma	HIF1A NDRG1	1.43e-05	2	112	2	C0206734
Disease	Disorder of eye	RPGRIP1L IMPDH1 OAT CRB1 EYS MFN2 CPLANE1	1.71e-05	212	112	7	C0015397
Disease	Chromosome Breakage	BRCA1 NFE2L2 SUV39H1	1.88e-05	14	112	3	C0376628
Disease	Chromosome Breaks	BRCA1 NFE2L2 SUV39H1	1.88e-05	14	112	3	C0333704
Disease	diabetic retinopathy (implicated_via_orthology)	HIF1A NFE2L2 KCNJ10	2.88e-05	16	112	3	DOID:8947 (implicated_via_orthology)
Disease	Primary biliary cirrhosis	HIF1A SLC4A2 NFE2L2 TNPO3	3.09e-05	47	112	4	C0008312
Disease	Cerebral Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0750935
Disease	Intracranial Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0750936
Disease	Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0004114
Disease	Grade I Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C1704230
Disease	Subependymal Giant Cell Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0205768
Disease	Mixed oligoastrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0547065
Disease	Pilocytic Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0334583
Disease	Juvenile Pilocytic Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0280783
Disease	Diffuse Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0280785
Disease	Childhood Cerebral Astrocytoma	HIF1A MET NDRG1	1.15e-04	25	112	3	C0338070
Disease	Gemistocytic astrocytoma	HIF1A MET NDRG1	1.30e-04	26	112	3	C0334581
Disease	Protoplasmic astrocytoma	HIF1A MET NDRG1	1.30e-04	26	112	3	C0334580
Disease	Fibrillary Astrocytoma	HIF1A MET NDRG1	1.30e-04	26	112	3	C0334582
Disease	Anaplastic astrocytoma	HIF1A MET NDRG1	1.46e-04	27	112	3	C0334579
Disease	ovarian neoplasm	BRIP1 MUC16 MET BRCA1 MKI67	1.63e-04	134	112	5	C0919267
Disease	Malignant neoplasm of ovary	BRIP1 MUC16 MET BRCA1 MKI67	1.81e-04	137	112	5	C1140680
Disease	growth/differentiation factor 5 measurement	LECT2 TGFBI	2.12e-04	6	112	2	EFO_0020429
Disease	Glioblastoma	HIF1A TES MET NDRG1	2.37e-04	79	112	4	C0017636
Disease	Giant Cell Glioblastoma	HIF1A TES MET NDRG1	3.00e-04	84	112	4	C0334588
Disease	Congenital Amaurosis of Retinal Origin	IMPDH1 CRB1	3.94e-04	8	112	2	C3540662
Disease	transforming growth factor-beta-induced protein ig-h3 measurement	LECT2 TGFBI	3.94e-04	8	112	2	EFO_0008302
Disease	creatinine measurement	HIF1A BRIP1 IMPDH2 SPEG LAMA2 PHF7 CUBN BIRC6 NDRG1 NFE2L2 PRRC2C MBD5	4.05e-04	995	112	12	EFO_0004518
Disease	Nodular glomerulosclerosis	TGFBI NFE2L2 MFN2	5.11e-04	41	112	3	C0017667
Disease	Schizophrenia	CAMK2B GNB1L LAMA2 CSMD2 NDUFV1 PCDH17 MED15 MET PTPRA BRCA1 TET1	5.45e-04	883	112	11	C0036341
Disease	Secondary Biliary Cholangitis	HIF1A SLC4A2 NFE2L2	5.49e-04	42	112	3	C0238065
Disease	Biliary cirrhosis	HIF1A SLC4A2 NFE2L2	5.49e-04	42	112	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	HIF1A SLC4A2 NFE2L2	5.49e-04	42	112	3	C4551595
Disease	asthma	ZBTB38 SPEM2 MUC16 SRGAP2 LDLRAD3 PRAG1 JMJD1C CRB1 GLI3 METTL25	5.90e-04	751	112	10	MONDO_0004979
Disease	Diabetic Nephropathy	TGFBI NFE2L2 MFN2	6.29e-04	44	112	3	C0011881
Disease	Malignant neoplasm of kidney	KYAT1 MET NDRG1	6.73e-04	45	112	3	C0740457
Disease	diabetic retinopathy (biomarker_via_orthology)	HIF1A KCNJ10 MFN2	6.73e-04	45	112	3	DOID:8947 (biomarker_via_orthology)
Disease	Copper-Overload Cirrhosis	MET MKI67	7.68e-04	11	112	2	C1876165
Disease	cognitive decline measurement, memory performance, language measurement	GLI3 TNFAIP2	7.68e-04	11	112	2	EFO_0004874, EFO_0007710, EFO_0007797
Disease	Hypermetropia, Myopia	ZBTB38 LAMA2 METAP1D CUBN TNPO3	7.88e-04	189	112	5	HP_0000540, HP_0000545
Disease	Malignant neoplasm of breast	HIF1A BRIP1 GNB1L LAMA2 PHF7 CUBN MCOLN1 NDRG1 BRCA1 KCNJ1 MKI67 FTO	7.94e-04	1074	112	12	C0006142
Disease	Ciliopathies	RPGRIP1L IMPDH1 CRB1 CPLANE1	8.33e-04	110	112	4	C4277690
Disease	Glioblastoma Multiforme	HIF1A TES MET NDRG1	8.62e-04	111	112	4	C1621958
Disease	response to fenofibrate	JMJD1C GLI3 C6	9.16e-04	50	112	3	GO_1901557
Disease	prediabetes syndrome (biomarker_via_orthology)	SLC4A2 MFN2	9.19e-04	12	112	2	DOID:11716 (biomarker_via_orthology)
Disease	Squamous cell carcinoma of the head and neck	MET NDRG1 NFE2L2	1.03e-03	52	112	3	C1168401
Disease	blood nickel measurement	MUC16 PLPPR1 EYS FAT2	1.15e-03	120	112	4	EFO_0007583
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRIP1 BRCA1	1.26e-03	14	112	2	C0677776
Disease	refractive error	ZBTB38 LAMA2 SCRG1 METAP1D SLC39A8 KCNJ1	1.56e-03	326	112	6	MONDO_0004892
Disease	acute kidney failure (biomarker_via_orthology)	HIF1A MET NFE2L2	1.63e-03	61	112	3	DOID:3021 (biomarker_via_orthology)
Disease	Leber congenital amaurosis	IMPDH1 CRB1	1.65e-03	16	112	2	cv:C0339527
Disease	idiopathic scoliosis (implicated_via_orthology)	SSPOP SLC39A8	1.65e-03	16	112	2	DOID:0060250 (implicated_via_orthology)
Disease	type 2 diabetes mellitus (is_marker_for)	HIF1A F8 MFN2 FTO	1.83e-03	136	112	4	DOID:9352 (is_marker_for)
Disease	pre-malignant neoplasm (biomarker_via_orthology)	GLI3 SUV39H1	1.87e-03	17	112	2	DOID:0060071 (biomarker_via_orthology)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MET MKI67	1.87e-03	64	112	3	DOID:4947 (is_marker_for)
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	HIF1A NFE2L2 MKI67 FTO	2.42e-03	147	112	4	DOID:9352 (biomarker_via_orthology)
Disease	sarcopenia	LDLRAD3 FTO	2.59e-03	20	112	2	EFO_1000653
Disease	Familial aplasia of the vermis	RPGRIP1L CPLANE1	2.59e-03	20	112	2	cv:C0431399
Disease	pentachlorophenol measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022071
Disease	parathion measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022055
Disease	aldrin measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022054
Disease	dicofol measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022060
Disease	disulfoton measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022062
Disease	dieldrin measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022061
Disease	endrin measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022064
Disease	endosulfan measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022063
Disease	heptachlor measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022066
Disease	ethion measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022056
Disease	diazinon measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 PLPPR1 EYS	2.73e-03	73	112	3	EFO_0008360
Disease	Retinitis pigmentosa	IMPDH1 CRB1 EYS	2.84e-03	74	112	3	cv:C0035334
Disease	DDT metabolite measurement	MUC16 PLPPR1 EYS	2.84e-03	74	112	3	EFO_0007886
Disease	Left Ventricle Remodeling	NFE2L2 MFN2	2.86e-03	21	112	2	C0600520
Disease	Ventricular Remodeling	NFE2L2 MFN2	2.86e-03	21	112	2	C0600519
Disease	kidney disease (biomarker_via_orthology)	TGFBI MKI67	2.86e-03	21	112	2	DOID:557 (biomarker_via_orthology)
Disease	BREAST CANCER	BRIP1 BRCA1	2.86e-03	21	112	2	114480
Disease	Mental Depression	HIF1A DEAF1 CSMD2 BRCA1 FTO	2.89e-03	254	112	5	C0011570
Disease	Non-Small Cell Lung Carcinoma	HIF1A MET NDRG1 NFE2L2	3.00e-03	156	112	4	C0007131
Disease	transient cerebral ischemia (biomarker_via_orthology)	HIF1A KCNJ10 MFN2 FTO	3.07e-03	157	112	4	DOID:224 (biomarker_via_orthology)
Disease	nucleus accumbens volume	BIRC6 SLC39A8	3.14e-03	22	112	2	EFO_0006931
Disease	Hepatitis, Chronic	MET MKI67	3.14e-03	22	112	2	C0019189
Disease	Chronic active hepatitis	MET MKI67	3.14e-03	22	112	2	C0520463
Disease	Chronic Persistent Hepatitis	MET MKI67	3.14e-03	22	112	2	C0149519
Disease	Leber Congenital Amaurosis	IMPDH1 CRB1	3.14e-03	22	112	2	C0339527
Disease	Cryptogenic Chronic Hepatitis	MET MKI67	3.14e-03	22	112	2	C0524611
Disease	Carcinomatosis	HIF1A KYAT1 MET BRCA1	3.51e-03	163	112	4	C0205699
Disease	Carcinoma, Spindle-Cell	HIF1A KYAT1 MET BRCA1	3.51e-03	163	112	4	C0205697
Disease	Undifferentiated carcinoma	HIF1A KYAT1 MET BRCA1	3.51e-03	163	112	4	C0205698

Protein segments in the cluster

Peptide	Gene	Start	Entry
QIPSFSNHCGTQEQE	TDG	391	Q13569
NVHTSLSHVQNGAPF	ZNF280B	221	Q86YH2
QIHHYPNGIVTVNCA	TGFBI	201	Q15582
IFQEHPLHGCSASNS	SLC4A2	846	P04920
HSPNCPFVKGEHTQN	BIRC6	351	Q9NR09
SHHPRSAGQNCTFQL	CSMD2	16	Q7Z408
TGHPVLTCQHGTNRN	CSMD2	2156	Q7Z408
QNPCHSSTHCLNNVG	ADGRE2	171	Q9UHX3
PNVSALHCQHLGNVA	ADGRA2	736	Q96PE1
EGHAQNVSCASFHPE	COPB2	226	P35606
CHSQDFSVHGNIING	CPXM1	551	Q96SM3
SHAVCNAQHDLPLSN	GKAP1	86	Q5VSY0
HFQCPHNSSNNANVT	CD79A	51	P11912
GHCHPLVVQAAHEQN	PHYKPL	61	Q8IUZ5
HCVDRHPNQQHVVAT	NUP43	221	Q8NFH3
PGSHQHSEQQQVCVT	REC114	181	Q7Z4M0
NNLTVPQGHAGCHTS	PCDH17	821	O14917
IQECKHPSVFQHGDN	MCOLN1	281	Q9GZU1
DQAVPLHLACQQGHF	ANKRD27	776	Q96NW4
ATGVDAICTHHLNPQ	MUC16	13076	Q8WXI7
PHHCNVTYNVNNGIQ	LDLRAD3	226	Q86YD5
DSHAGQQFHALEQPC	GLI3	1136	P10071
SPVHALHFCEGAQAQ	GNB1L	21	Q9BYB4
HITHQNGFQVCPHFV	METAP1D	236	Q6UB28
QPHVCFHGNCSNITS	EYS	261	Q5T1H1
FSQHAVVASHNGKPC	KCNJ10	181	P78508
QHTQVYQKEQCPAGH	NEIL2	281	Q969S2
SQVDGITGACHHTQP	RPGRIP1L	1131	Q68CZ1
FHHVQQSQGCIAVNF	JMJD7	276	P0C870
LNATHQHCVLAGSQP	FTO	301	Q9C0B1
GHIHVYDTNSNQPQC	HIF1A	196	Q16665
IHHNCTPEFQANEVR	IMPDH2	91	P12268
NCTGQNEHQRENSGH	MED7	196	O43513
LHSQPHQEENLCFEN	METTL25	296	Q8N6Q8
PAGALHQVQNFHSCI	JMJD1C	2461	Q15652
ANHVQCNTHPFDNEV	KDM5D	171	Q9BY66
DHVGCVNTVHFNQRG	DCAF8L2	226	P0C7V8
TCQGQICHNTVHLDP	FAT2	3731	Q9NYQ8
HVAPHCANFLVPSQN	LENG9	346	Q96B70
CQNNIIPHTFCEHIG	OR52B4	171	Q8NGK2
EQPSVCGSHTICNNH	NID1	716	P14543
TQHFAVCHVDAPGQQ	NDRG1	86	Q92597
QGQSTHVHDAQCENT	NFE2L2	411	Q16236
KTHQHHNPNEAEQCG	FAM214A	246	Q32MH5
VNLDPSHCSNNGTVH	MED15	691	Q96RN5
PGIQSHVHIENCDSS	LECT2	131	O14960
PSQAGNAFQEHTAHI	LAX1	131	Q8IWV1
PETSICQNCQHHTAG	LAMA2	1431	P24043
VCHTNTLNPAHGRQV	F8	1876	P00451
EVHSQFSTGHANSPC	MKI67	701	P46013
TLTCFEHNLQGNAHS	OSTM1	196	Q86WC4
NAQSQHCSPIQSHPS	PHC3	366	Q8NDX5
SQYSPAIEGHCNNIH	NCKAP1	1016	Q9Y2A7
HQVQQELSGTFAHLC	MFN2	686	O95140
IHHNCTPEFQANEVR	IMPDH1	91	P20839
CDEQGTLHGQPTYHQ	PASD1	711	Q8IV76
HTCVHPEVVGNFNRN	BRIP1	281	Q9BX63
VSNLHVEPCGTNTHA	BRCA1	266	P38398
THPSCNNEHVIVFNG	CUBN	2501	O60494
TLTAQGQQFHCHKAV	KLHL14	36	Q9P2G3
NQQLHFLHIGSCQDG	C6	826	P13671
HTLSHQDNFSPGQEV	CR1	1661	P17927
TFQKGSNAPCHSLQH	CPLANE1	3076	Q9H799
HQHICGQSAAVTVQA	DEAF1	536	O75398
LIHSQSNVQQNVCHG	FOXJ3	521	Q9UPW0
NHHVVNNTLEGNCSS	GNS	106	P15586
CHNANTNFVHSNSPV	MBD5	761	Q9P267
THQQCLNNGTCIPHF	CRB1	446	P82279
LNNGTCIPHFQDGQH	CRB1	451	P82279
QHFEAVHSGTPVTNN	SPACA9	81	Q96E40
NCGNTSVHHGAPLQL	RXYLT1	361	Q9Y2B1
QQSGNHPITVHCSAG	PTPRA	721	P18433
HFQHQSPTVPNCLST	HOXA2	286	O43364
SSHFPCSESQQHLNG	NR1D2	306	Q14995
CQRHVFPHNHTADIQ	MET	141	P08581
QNVHFHCSGAPVAPL	CAMK2B	651	Q13554
NHAVVCQGCHNAIDP	TES	356	Q9UGI8
QTEPCEGCEHQGQVH	SSPOP	1961	A2VEC9
CQRNDLNEEPQHFTH	NTN4	236	Q9HB63
PTQNIQHGHVGEESC	PHF7	146	Q9BWX1
FNISGHVNHPCTVEE	NDUFV1	276	P49821
TVHQNSVFHCPTQSQ	KYAT1	271	Q16773
TQCGVVPHQVFRNHL	SH2D5	336	Q6ZV89
SGTAIHNFPTVQHQE	PRRC2C	2486	Q9Y520
LHQASFPVETNCGHL	RNF170	91	Q96K19
KHFVVCHVDAPGQQV	NDRG4	61	Q9ULP0
CHVDAPGQQVGASQF	NDRG4	66	Q9ULP0
CHQFPHGITDQVIQN	POLR3F	26	Q9H1D9
HNCHNLPEGVADLTQ	SCRG1	36	O75711
AHHQFINNGNICTGD	PLPPR1	171	Q8TBJ4
SAVNQGHCHPKIVNA	OAT	86	P04181
GNISHFVNHSCDPNL	SUV39H1	316	O43463
HPEAQGTTQCQRTEH	SEMA5A	21	Q13591
QQPGFNCSSIPHSSH	TET1	826	Q8NFU7
QHEAAVQHPSSIIGC	B3GNTL1	126	Q67FW5
HQHSEKGLVDTPCFQ	C15orf62	121	A8K5M9
GSCPHSGDVHIQINS	RNFT1	71	Q5M7Z0
NADTIQHFCTQHGSP	TNFAIP2	556	Q03169
NNHQRTHTGEKPYQC	ZNF157	346	P51786
HPVTCSHFNQDLQPE	ZNF735	86	P0CB33
VSAVNTHGQAHCSAQ	SPEG	1136	Q15772
AQGCREHHSPQSHQQ	SPEM2	336	Q0P670
VPEGHDQVSCQAHVN	SRGAP2	651	O75044
PEQLNHAFHTCGVFS	TMEM50B	51	P56557
VPVHFNIQQDCGHFV	PRAG1	1041	Q86YV5
NIQQDCGHFVASVPS	PRAG1	1046	Q86YV5
HQRVHTGQKPFQCNE	ZNF33A	346	Q06730
HTNPIVENGQTHPCQ	TNPO3	621	Q9Y5L0
NAENNVPSCHHSQPA	ZGRF1	1341	Q86YA3
CYANPAVTEANGHIH	SLC39A8	256	Q9C0K1
HQRTHTGEKPYNCNQ	ZNF782	636	Q6ZMW2
VCHENSNPLENQHFI	ZBTB38	1161	Q8NAP3
SHASGLNHNPACESV	TTLL4	426	Q14679
QHDFSSQIFSLGHCP	TLE2	626	Q04725
TFCSGLIQHQQNHTD	ZNF850	711	A8MQ14
ECHQIFNQSPSFNEH	ZNF606	321	Q8WXB4
HQVVPPQSSFASCVH	ZAN	1756	Q9Y493
EFHPSANHTPCVENI	KCNJ1	111	P48048
NNFQHSVNVSCAHPE	LRIG2	461	O94898